Small-Molecule Injectable Market
Market Insights on Small-Molecule Injectable covering sales outlook, demand forecast & up-to-date key trends
Small-Molecule Injectable Market by Product (Small Molecule Antibiotics, Chemotherapy Agents, Local and General Anaesthetics), Application ( Oncology, Pain Management, Cardiovascular Diseases), Route of Administration (Intravenous, Intramuscular, Subcutaneous), End User & Region - Forecast to 2021-2031
Small-Molecule Injectable Market Snapshot
[270 Pages Report] The global Small-molecule Injectable Market was valued at US$ 52.7 Bn in 2020 and is expected to reach US$ 112.9 Bn by 2031, finds Future Market Insights (FMI) in a recent market survey.
Increasing application of analgesics and antibiotics during surgeries for preventing infections and reduce sensitization is spurring the demand for small-molecule injectables. Driven by this, sales of small-molecule injectables are expected to rise at a 7.3% CAGR through 2031.
Small Molecule Injectable Market Outlook:
Data Points |
Market Insights |
Market Value 2020 |
USD 52.75 Bn |
Market Value 2021 |
USD 55.77 Bn |
CAGR 2021-2031 |
7.3% |
Key Players |
The key players in Small molecule injectable market are Aurobindo Pharma Limited, Sun Pharmaceutical Industries Ltd, Novartis AG, and Merck & Co. Inc |
Let us know your requirement to get
100% FREE customization
2016-2020 Small Molecule Injectable Market Demand Outlook Compared to 2021-2031 Forecast
Sales of small molecule injectable grew at a CAGR of 4.8% between 2016 and 2020. Growing prevalence of chronic diseases and fast track approvals of new drugs for treatment are expected to drive sales of small molecule injectables.
Leading pharmaceutical companies are aiming at production facility expansion through mergers acquisitions and collaborations to improve their product portfolios. For Instance, In April 2021, Dr. Reddy's Laboratories announced the launch of a generic version of Sapropterin Dihydrochloride powder for oral solution, 100 mg in the U.S. Market.
In July, 2020, USFDA cGMP inspection completed at Cipla's API manufacturing facility in Virgonagar, Bengaluru. These developments are expected to bode well for the global small-molecule injectables market.
Considering this, FMI expects the global small molecule injectable to grow at a CAGR of 7.3% through 2031.
Which Factors Are Restraining Demand for Small Molecule Injectable?
Small-molecule injectables require complex equipment for manufacturing, each of which need proper certification and sterilization before production. This leads to high operating costs and high debt levels too due to purchase and renting of capital equipment.
In addition to this, regulatory cost burden is high due to FDA mandates for maintaining quality of product while manufacturing,packaging, storage and distribution.
Monopoly in manufacturing and sourcing of small-molecule injectables is also causing disruptions in supply chain. This might hamper the availability of drugs, resulting in dampened sales prospects for small-molecule injectables.
What is the Impact of the COVID-19 Crisis on the Small-Molecule Injectable Market?
The COVID-19 pandemic is anticipated to have a negative impact on the small molecule injectable market due to limited production and transportation-related delays. Lockdown restrictions further made it difficult for freight service providers to deliver raw material.
However, resumption in production activities and across various sectors is expected to augment recovery of the small-molecule injectables market in the forthcoming years. Manufacturers and healthcare professionals are also amplifying their efforts to spread awareness regarding immunotherapy treatment options. This is expected to propel sales of small-molecule injectables over the forecast period.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystCountry-wise Insights
Will the U.S. Remain a Key Small-Molecule Injectable Market?
The U.S. is estimated to account for over 92.4 % of the North America small-molecule injectable market in 2021. Demand for small-molecule injectables is increasing in the U.S due to increasing incidence of chronic diseases among the geriatric population, and growing rates of hospitalisation and surgeries.
Why is Germany Considered a Lucrative Small-Molecule Injectable Market?
Germany is expected to account for 21.9% of the Europe small-molecule injectable market in Europe by 2031. Growing demand for small-molecule injectables in Germany is attributable to rapid expansion of healthcare infrastructure, presence of prominent players and rapid adoption of technologically advanced equipment and processes in the healthcare sector.
What are the Factors Fueling Small-Molecule Injectable Sales in China?
Sales of small-molecule injectables in China are projected to grow at a 9.0% CAGR in East Asia throughout the forecast period. Increasing use of oncology-related medicines in hospitals for treatment of various types of cancer, rising demand for analgesics for surgical pain management and wide avaiblity of biopharmaceutical raw material are expected to continue pushing sales of small-molecule injectables in China.
How will the Small-Molecule Injectable Market Expand Across India?
Demand for small-molecule injectables in India is expected to rise at an impressive 11.1% CAGR over the forecast period. Rising health care awareness, surging demand for advanced medical technologies, increasing number of hospitalization, and streamlined raw material procurement are expected to drive expansion of the small-molecule injectable market in India.
Category-wise Insights
Demand for Analgesics to Continue gaining Traction
By product, the analgesics segment is anticipated to hold the maximum share of 23.9% in 2021, expanding at 8.0% CAGR during the forecast period. Revenues from analgesics are expected to expand further, primarily due to increasing number of accidents, surgeries and hospitalizations. Analgesics help in pain management, relieve anxiety, improve healing and accelerate recovery.
Applications of Small-Molecule Injectables in Infectious Diseases to Remain High
In terms of application, the infectious disease sement in projected to account for 31.7% of the total market share in 2021. Increasing adoption of small-molecules injectable drug in infectious disease control and treatment is expected to continue spurring demand for small-molecule injectables during the forecast period.
Which Route of Administration will be Most Preferred?
By route of administration, the intravenous segment is projected to account for 49.8% of the total market share in 2021. Intravenous route is considered to be the fastest route of drug administration and injectable are directly introduced into the bloodstream. Considering this, sales of small-molecule injectables in the intravenous route of administration segement are expected to remain high over the forecast period.
Sales of Small-Molecule Injectables through Hospital Pharmacies to Remain High
By distribution channel, hospital pharmacies are anticipated to account for 67.8% of the total small-molecule injectable market share in 2021. Increasing hospitalizations, and the availability of skilled professionals to inject drugs is likely to fuel growth of the segment.

A unified Market Research Subscription Platform, built for today's disparate research needs.
Competitive Landscape
Companies operating in the small molecule Injectable are investing in strategic collaborations, mergers and acquisitions to improve their product portfolios. Drug approvals and production facility expansions will remain a part pf growth strategies adopted by market players to gain a competitive edge. For instance:
- In March 2021, U.S. Food and Drug Administration (FDA) has accepted new drug application for gefapixant, an intravenous administered for the treatment of refractory chronic cough (RCC) in adults.
- In 2021, Novartis announced that small drug molecule (branaplam) is in Phase 2 for spinal muscular atrophy.
- In Jan 2020, Sanofi S.A acquired Syntrox for biotechnological product development for cancer and autoimmune disorders.
Scope of the Report
Attribute |
Details |
Forecast Period |
2021-2031 |
Historical Data Available for |
2016-2020 |
Market Analysis |
USD Million for Volume |
Key Countries Covered |
US, Canada, Germany, U.K., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, South Africa |
Key Segments Covered |
Product, Application, Route of Administration, Distribution Channel and Region |
Key Companies Profiled |
|
Report Coverage |
Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
Customization & Pricing |
Available upon Request |
Key Questions Answered in Report
-
What is the current value of the global small-molecule injectable market?
The global small-molecule injectable market is projected to expand at a 7.3% CAGR over the forecast period.
-
At what rate did the market grow between 2016 and 2020?
The global small-molecule injectable market expanded at a 4.8% CAGR between 2016 and 2020.
-
What are key trends driving sales of small-molecule injectables?
Increasing adoption of automation in drug production, focus on manufacturing quality, product launch, rising government initiatives and growing market consolidation activities by manufacturer are key trends driving sales of small molecule injectable across the globe.
-
What are the key market statistics of South Korea and Japan?
The South Korea small molecule injectable market is projected to expand at a 5.0% CAGR during the forecast period. Sales of small-molecule injectables in Japan are slated to grow at a 8.8% CAGR during the forecast period.
-
What are the top 5 countries driving demand for small molecule injectable market?
The U.S., China, India, Germany, and Japan are top 5 countries that are driving demand for small molecule injectable market
-
Which are leading companies of small molecule injectable market?
Leading companies of small molecule injectable are Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Sanofi S.A S.A., Sun Pharmaceutical Industries Ltd., AstraZeneca Plc, Merck & Co., Inc., Mylan N.V, Cipla Inc., and Dr. Reddy’s Laboratories Ltd.
Small Molecule Injectable Market by Category
By Product:
- Small Molecule Antibiotics
- Chemotherapy Agents
- Local and General Anaesthetics
- Skeletal Muscle Relaxants
- Analgesics
- Anticoagulants
- Anticonvulsants
- Antivirals
- Anti-histamines/ Anti-allergy
- Others
By Application:
- Oncology
- Pain Management
- Cardiovascular Diseases
- Infectious Diseases
- CNS Diseases
- Blood Disorders
- Musculoskeletal Disorders
- Others
By Route of Administration:
- Intravenous (IV)
- Intramuscular (IM)
- Subcutaneous (SC)
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Mail Order Pharmacies
Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East and Africa (MEA)
Frequently Asked Questions
What is the current value of the global small-molecule injectable market?
The global small-molecule injectable market is projected to expand at a 7.3% CAGR over the forecast period.
At what rate did the market grow between 2016 and 2020?
The global small-molecule injectable market expanded at a 4.8% CAGR between 2016 and 2020.
What are key trends driving sales of small-molecule injectables?
Increasing adoption of automation in drug production, focus on manufacturing quality, product launch, rising government initiatives and growing market consolidation activities by manufacturer are key trends driving sales of small molecule injectable across the globe.
What are the key market statistics of South Korea and Japan?
The South Korea small molecule injectable market is projected to expand at a 5.0% CAGR during the forecast period. Sales of small-molecule injectables in Japan are slated to grow at a 8.8% CAGR during the forecast period.
What are the top 5 countries driving demand for small molecule injectable market?
The U.S., China, India, Germany, and Japan are top 5 countries that are driving demand for small molecule injectable market
Which are leading companies of small molecule injectable market?
Leading companies of small molecule injectable are Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Sanofi S.A S.A., Sun Pharmaceutical Industries Ltd., AstraZeneca Plc, Merck & Co., Inc., Mylan N.V, Cipla Inc., and Dr. Reddy’s Laboratories Ltd.
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation /Development Trends 4. Key Success Factors 4.1. Adoption Analysis, by Region 4.2. Key Disease Epidemiology, By Region 4.3. Pipeline Assessment 4.4. Regulatory Scenario 4.5. Supply Chain 4.6. Key promotional Strategies by Manufacturers 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Expenditure Outlook 5.1.3. Growth of Healthcare Sector in Emerging Nations 5.2. Forecast Factors - Relevance & Impact 5.2.1. Increasing Adoption of Small MoleculeSmall-Molecule Injectable 5.2.2. Increasing Demand of Small MoleculeSmall-Molecule Injectable Fromfrom Pain management and Oncology 5.2.3. Frequent Drug Shortages 5.2.4. Geographical expansion 5.2.5. Change in regulatory Scenario 5.2.6. Increasing Affordability of Small MoleculeSmall-Molecule Injectable 5.2.7. R&D in Small MoleculeSmall-Molecule Injectable 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID19 Crisis Analysis 6.1. Current COVID19 Probable Future Impact 6.2. Current GDP Projection and Probable Impact 6.3. Current Economic Projection as compared to 2008 Economic analysis 6.4. COVID19 and Impact Analysis 6.5. 2020 Market Scenario 7. Global Small MoleculeSmall-Molecule Injectable Market Demand (in US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031 7.1. Historical Market Value (US$ Mn) Analysis, 2016-2020 7.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Small MoleculeSmall-Molecule Injectable Market Analysis 2016-2020 and Forecast 2021-2031, by Product 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) Trend Analysis By Product, 2016–2020 8.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Product, 2021-2031 8.3.1. Small MoleculeSmall-Molecule Antibiotics 8.3.2. Chemotherapy Agents 8.3.3. Local and General AnaestheticsAnesthetics 8.3.4. Skeletal Muscle Relaxants 8.3.5. Analgesics 8.3.6. Anticoagulants 8.3.7. Anticonvulsants 8.3.8. Antivirals 8.3.9. Anti-histamines/ Anti-allergy 8.3.10. Others 8.4. Market Attractiveness Analysis By Product 9. Global Small MoleculeSmall-Molecule Injectable Market Analysis 2016-2020 and Forecast 2021-2031, by Application 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Mn) Trend Analysis By Application, 2016–2020 9.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Application, 2021-2031 9.3.1. Oncology 9.3.2. Pain Management 9.3.3. Cardiovascular Diseases 9.3.4. Infectious Diseases 9.3.5. CNS Diseases 9.3.6. Blood Disorders 9.3.7. Musculoskeletal Disorders 9.3.8. Others 9.4. Market Attractiveness Analysis By Application 10. Global Small MoleculeSmall-Molecule Injectable Market Analysis 2016-2020 and Forecast 2021-2031, by Route of Administration 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2016–2020 10.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Route of Administration, 2021-2031 10.3.1. Intravenous 10.3.2. Intramuscular 10.3.3. Subcutaneous 10.4. Market Attractiveness Analysis By Route of Administration 11. Global Small MoleculeSmall-Molecule Injectable Market Analysis 2016-2020 and Forecast 2021-2031, by Distribution Channel 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2016–2020 11.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Distribution Channel, 2021-2031 11.3.1. Hospital Pharmacies 11.3.2. Retail Pharmacies 11.3.3. Drug Stores 11.3.4. Mail Order Pharmacies 11.4. Market Attractiveness Analysis By Distribution Channel 12. Global Small MoleculeSmall-Molecule Injectable Market Analysis 2016-2020 and Forecast 2021-2031, by Region 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2016–2020 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2021-2031 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. South Asia 12.3.5. East Asia 12.3.6. Oceania 12.3.7. Middle East & Africa 12.4. Market Attractiveness Analysis By Region 13. North America Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020 13.3. Market Size (US$ Mn) Trend Analysis and Forecast By Market Taxonomy, 2021-2031 13.3.1. By Country 13.3.1.1.1. U.S. 13.3.1.1.2. Canada 13.3.2. By Product 13.3.3. By Application 13.3.4. By Route of Administration 13.3.5. By Distribution Channel 13.4. Market Attractiveness Analysis 13.5. Drivers and Restraints - Impact Analysis 13.6. Key Market Participants - Intensity Mapping 14. Latin America Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020 14.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Market Taxonomy, 2021-2031 14.3.1. By Country 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Argentina 14.3.1.4. Rest of Latin America 14.3.2. By Product 14.3.3. By Application 14.3.4. By Route of Administration 14.3.5. By Distribution Channel 14.4. Market Attractiveness Analysis 14.5. Drivers and Restraints - Impact Analysis 14.6. Key Market Participants - Intensity Mapping 15. Europe Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020 15.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Market Taxonomy, 2021-2031 15.3.1. By Country 15.3.1.1. Germany 15.3.1.2. Italy 15.3.1.3. France 15.3.1.4. U.K. 15.3.1.5. Spain 15.3.1.6. BENELUX 15.3.1.7. Russia 15.3.1.8. Rest of Europe 15.3.2. By Product 15.3.3. By Application 15.3.4. By Route of Administration 15.3.5. By Distribution Channel 15.4. Market Attractiveness Analysis 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 16. South Asia Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020 16.3. Current and Future Market Size (US$ Mn) and Volume (Absolute) Trend Analysis and Forecast By Market Taxonomy, 2021-2031 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Thailand 16.3.1.3. Indonesia 16.3.1.4. Malaysia 16.3.1.5. Rest of South Asia 16.3.2. By Product 16.3.3. By Application 16.3.4. By Route of Administration 16.3.5. By Distribution Channel 16.4. Market Attractiveness Analysis 16.5. Drivers and Restraints - Impact Analysis 16.6. Key Market Participants - Intensity Mapping 17. East Asia Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020 17.3. Current and Future Market Size (US$ Mn) and Volume (Absolute) Trend Analysis and Forecast By Market Taxonomy, 2021-2031 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.2. By Product 17.3.3. By Application 17.3.4. By Route of Administration 17.3.5. By Distribution Channel 17.4. Market Attractiveness Analysis 17.5. Drivers and Restraints - Impact Analysis 17.6. Key Market Participants - Intensity Mapping 18. Oceania Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020 18.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Market Taxonomy, 2021-2031 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Product 18.3.3. By Application 18.3.4. By Route of Administration 18.3.5. By Distribution Channel 18.4. Market Attractiveness Analysis 18.5. Drivers and Restraints - Impact Analysis 18.6. Key Market Participants - Intensity Mapping 19. Middle East and Africa Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031 19.1. Introduction 19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016–2020 19.3. Current and Future Market Size (US$ Mn) Trend Analysis and Forecast By Market Taxonomy, 2021-2031 19.3.1. By Country 19.3.1.1. GCC Countries 19.3.1.2. Turkey 19.3.1.3. Northern Africa 19.3.1.4. South Africa 19.3.1.5. Rest of Middle East and Africa 19.3.2. By Product 19.3.3. By Application 19.3.4. By Route of Administration 19.3.5. By Distribution Channel 19.4. Market Attractiveness Analysis 19.5. Drivers and Restraints - Impact Analysis 19.6. Key Market Participants - Intensity Mapping 20. Key and Emerging Countries Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031 20.1. Introduction 20.1.1. Market Value Proportion Analysis, By Key Countries 20.1.2. Global Vs. Country Growth Comparison 20.2. U.S. Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031 20.2.1. By Product 20.2.2. By Application 20.2.3. By Route of Administration 20.2.4. By Distribution Channel 20.3. Canada Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031 20.3.1. By Product 20.3.2. By Application 20.3.3. By Route of Administration 20.3.4. By Distribution Channel 20.4. Mexico Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031 20.4.1. By Product 20.4.2. By Application 20.4.3. By Route of Administration 20.4.4. By Distribution Channel 20.5. Brazil Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031 20.5.1. By Product 20.5.2. By Application 20.5.3. By Route of Administration 20.5.4. By Distribution Channel 20.6. Argentina Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031 20.6.1. By Product 20.6.2. By Application 20.6.3. By Route of Administration 20.6.4. By Distribution Channel 20.7. U.K. Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031 20.7.1. By Product 20.7.2. By Application 20.7.3. By Route of Administration 20.7.4. By Distribution Channel 20.8. Germany Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031 20.8.1. By Product 20.8.2. By Application 20.8.3. By Route of Administration 20.8.4. By Distribution Channel 20.9. France Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031 20.9.1. By Product 20.9.2. By Application 20.9.3. By Route of Administration 20.9.4. By Distribution Channel 20.10. Italy Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031 20.10.1. By Product 20.10.2. By Application 20.10.3. By Route of Administration 20.10.4. By Distribution Channel 20.11. Spain Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031 20.11.1. By Product 20.11.2. By Application 20.11.3. By Route of Administration 20.11.4. By Distribution Channel 20.12. BENELUX Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031 20.12.1. By Product 20.12.2. By Application 20.12.3. By Route of Administration 20.12.4. By Distribution Channel 20.13. Russia Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031 20.13.1. By Product 20.13.2. By Application 20.13.3. By Route of Administration 20.13.4. By Distribution Channel 20.14. China Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031 20.14.1. By Product 20.14.2. By Application 20.14.3. By Route of Administration 20.14.4. By Distribution Channel 20.15. Japan Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031 20.15.1. By Product 20.15.2. By Application 20.15.3. By Route of Administration 20.15.4. By Distribution Channel 20.16. South Korea Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031 20.16.1. By Product 20.16.2. By Application 20.16.3. By Route of Administration 20.16.4. By Distribution Channel 20.17. India Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031 20.17.1. By Product 20.17.2. By Application 20.17.3. By Route of Administration 20.17.4. By Distribution Channel 20.18. ASEAN Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031 20.18.1. By Product 20.18.2. By Application 20.18.3. By Route of Administration 20.18.4. By Distribution Channel 20.19. Australia Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031 20.19.1. By Product 20.19.2. By Application 20.19.3. By Route of Administration 20.19.4. By Distribution Channel 20.20. New Zealand Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031 20.20.1. By Product 20.20.2. By Application 20.20.3. By Route of Administration 20.20.4. By Distribution Channel 20.21. GCC Countries Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031 20.21.1. By Product 20.21.2. By Application 20.21.3. By Route of Administration 20.21.4. By Distribution Channel 20.22. Turkey Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031 20.22.1. By Product 20.22.2. By Application 20.22.3. By Route of Administration 20.22.4. By Distribution Channel 20.23. South Africa Small MoleculeSmall-Molecule Injectable Market Value (US$) Analysis, 2021 & 2031 20.23.1. By Product 20.23.2. By Application 20.23.3. By Route of Administration 20.23.4. By Distribution Channel 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Share Analysis of Top Players 21.3. Market Concentration 21.4. Market Presence Analysis 21.4.1. By Regional footprint of Players 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep Dive 22.3.1. Aurobindo Pharma Limited 22.3.1.1. Overview 22.3.1.2. Product Portfolio 22.3.1.3. Profitability by Market Segments (Product/Channel/Region) 22.3.1.4. Sales Footprint 22.3.1.5. Strategy Overview 22.3.1.5.1. Marketing Strategy 22.3.1.5.2. Product Strategy 22.3.1.5.3. Channel Strategy 22.3.2. Teva Pharmaceutical Industries Ltd. 22.3.2.1. Overview 22.3.2.2. Product Portfolio 22.3.2.3. Profitability by Market Segments (Product/Channel/Region) 22.3.2.4. Sales Footprint 22.3.2.5. Strategy Overview 22.3.2.5.1. Marketing Strategy 22.3.2.5.2. Product Strategy 22.3.2.5.3. Channel Strategy 22.3.3. Merck & Co. Inc. 22.3.3.1. Overview 22.3.3.2. Product Portfolio 22.3.3.3. Profitability by Market Segments (Product/Channel/Region) 22.3.3.4. Sales Footprint 22.3.3.5. Strategy Overview 22.3.3.5.1. Marketing Strategy 22.3.3.5.2. Product Strategy 22.3.3.5.3. Channel Strategy 22.3.4. AstraZeneca Plc 22.3.4.1. Overview 22.3.4.2. Product Portfolio 22.3.4.3. Profitability by Market Segments (Product/Channel/Region) 22.3.4.4. Sales Footprint 22.3.4.5. Strategy Overview 22.3.4.5.1. Marketing Strategy 22.3.4.5.2. Product Strategy 22.3.4.5.3. Channel Strategy 22.3.5. Pfizer Inc 22.3.5.1. Overview 22.3.5.2. Product Portfolio 22.3.5.3. Profitability by Market Segments (Product/Channel/Region) 22.3.5.4. Sales Footprint 22.3.5.5. Strategy Overview 22.3.5.5.1. Marketing Strategy 22.3.5.5.2. Product Strategy 22.3.5.5.3. Channel Strategy 22.3.6. Sun Pharmaceutical Industries Ltd. 22.3.6.1. Overview 22.3.6.2. Product Portfolio 22.3.6.3. Profitability by Market Segments (Product/Channel/Region) 22.3.6.4. Sales Footprint 22.3.6.5. Strategy Overview 22.3.6.5.1. Marketing Strategy 22.3.6.5.2. Product Strategy 22.3.6.5.3. Channel Strategy 22.3.7. Novartis AG 22.3.7.1. Overview 22.3.7.2. Product Portfolio 22.3.7.3. Profitability by Market Segments (Product/Channel/Region) 22.3.7.4. Sales Footprint 22.3.7.5. Strategy Overview 22.3.7.5.1. Marketing Strategy 22.3.7.5.2. Product Strategy 22.3.7.5.3. Channel Strategy 22.3.8. Baxter International 22.3.8.1. Overview 22.3.8.2. Product Portfolio 22.3.8.3. Profitability by Market Segments (Product/Channel/Region) 22.3.8.4. Sales Footprint 22.3.8.5. Strategy Overview 22.3.8.5.1. Marketing Strategy 22.3.8.5.2. Product Strategy 22.3.8.5.3. Channel Strategy 22.3.9. Fresenius Kabi 22.3.9.1. Overview 22.3.9.2. Product Portfolio 22.3.9.3. Profitability by Market Segments (Product/Channel/Region) 22.3.9.4. Sales Footprint 22.3.9.5. Strategy Overview 22.3.9.5.1. Marketing Strategy 22.3.9.5.2. Product Strategy 22.3.9.5.3. Channel Strategy 22.3.10. Cipla Ltd 22.3.10.1. Overview 22.3.10.2. Product Portfolio 22.3.10.3. Profitability by Market Segments (Product/Channel/Region) 22.3.10.4. Sales Footprint 22.3.10.5. Strategy Overview 22.3.10.5.1. Marketing Strategy 22.3.10.5.2. Product Strategy 22.3.10.5.3. Channel Strategy 22.3.11. Mylan N.V. 22.3.11.1. Overview 22.3.11.2. Product Portfolio 22.3.11.3. Profitability by Market Segments (Product/Channel/Region) 22.3.11.4. Sales Footprint 22.3.11.5. Strategy Overview 22.3.11.5.1. Marketing Strategy 22.3.11.5.2. Product Strategy 22.3.11.5.3. Channel Strategy 22.3.12. Sanofi S.A 22.3.12.1. Overview 22.3.12.2. Product Portfolio 22.3.12.3. Profitability by Market Segments (Product/Channel/Region) 22.3.12.4. Sales Footprint 22.3.12.5. Strategy Overview 22.3.12.5.1. Marketing Strategy 22.3.12.5.2. Product Strategy 22.3.12.5.3. Channel Strategy 22.3.13. Dr. Reddy’s Laboratories Ltd 22.3.13.1. Overview 22.3.13.2. Product Portfolio 22.3.13.3. Profitability by Market Segments (Product/Channel/Region) 22.3.13.4. Sales Footprint 22.3.13.5. Strategy Overview 22.3.13.5.1. Marketing Strategy 22.3.13.5.2. Product Strategy 22.3.13.5.3. Channel Strategy 23. Assumptions and Acronyms Used 24. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Expenditure on Health (% of GDP) by Country, 2016-2021 Table 02: Expenditure on Health (% of GDP) by Country, 2016-2021 Table 03: Global Small MoleculeSmall-Molecule Injectable Market Size Value (US$ Bn) Analysis 2016–2020 and Forecast 2021–2031 , By Product Table 04: Global Small MoleculeSmall-Molecule Injectable Market Size Value (US$ Bn) Analysis 2016–2020 and Forecast 2021–2031 , By Application Table 05: Global Small MoleculeSmall-Molecule Injectable Market Size Value (US$ Bn) Analysis 2016–2020 and Forecast 2021–2031 , By Route of Administration Table 06: Global Small MoleculeSmall-Molecule Injectable Market Size Value (US$ Bn) Analysis 2016–2020 and Forecast 2021–2031 , By Distribution Channel Table 07: Global Small MoleculeSmall-Molecule Injectable Market Size Value (US$ Bn) Analysis 2016–2020 and Forecast 2021–2031, By Region Table 08: North America Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Country Table 09: North America Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Product Table 10: North America Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Application Table 11: North America Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Route of Administration Table 12: North America Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Distribution Channel Table 13: Latin America Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Country Table 14: Latin America Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Product Table 15: Latin America Generic Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Application Table 16: Latin America Generic Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Route of Administration Table 17: Latin America Generic Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Distribution Channel Table 18: Europe Generic Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Country Table 19: Europe Generic Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Product Table 20: Europe Generic Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Application Table 21: Europe Generic Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Route of Administration Table 22 Europe Generic Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Distribution Channel Table 23: South Asia Generic Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Country Table 24: South Asia Generic Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Product Table 25: South Asia Generic Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Application Table 26: South Asia Generic Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Route of Administration Table 27: South Asia Generic Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Distribution Channel Table 28: East Asia Generic Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Country Table 29: East Asia Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Product Table 30: East Asia Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Application Table 31: East Asia Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Route of Administration Table 32: East Asia Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Distribution Channel Table 33: Oceania Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Country Table 34: Oceania Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Product Table 35: Oceania Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Application Table 36: Oceania Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Route of Administration Table 37: Oceania Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Distribution Channel Table 38: MEA Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Country Table 39: MEA Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Product Table 40: MEA Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Application Table 41: MEA Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Route of Administration Table 42: MEA Small MoleculeSmall-Molecule Injectable Market size (US$ Bn) Analysis 2016–2020 and Forecast 2021-2031 By Distribution Channel
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Small MoleculeSmall-Molecule Injectable Market Value Share, By Product (2021) Figure 02: Global Small MoleculeSmall-Molecule Injectable Market Value Share, By Application (2021) Figure 03: Global Small MoleculeSmall-Molecule Injectable Market Value Share, By Route of Administration (2021) Figure 04: Global Small MoleculeSmall-Molecule Injectable Market Value Share, By Distribution Channel (2021) Figure 05: Global Small MoleculeSmall-Molecule Injectable Market Value Share, By Region (2021) Figure 07: Pipeline Products Share (%), by Phase (2020) Figure 06: Pipeline Products Share (%), by Therapeutic Area (2020) Figure 08: Global Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2016-2020 Figure 09: Global Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021–2031 Figure 10: Global Small MoleculeSmall-Molecule Injectable Market Absolute $ Opportunity, 2021-2031 Figure 11: Global Small MoleculeSmall-Molecule Injectable Market Analysis by Product –2021 & 2031 Figure 12: Global Small MoleculeSmall-Molecule Injectable Market Y-o-Y Growth Projections by Product, 2021-2031 Figure 13: Global Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Product, 2021–2031 Figure 14: Global Small MoleculeSmall-Molecule Injectable Market Share Analysis (%) By Application, 2021 & 2031 Figure 15: Global Small MoleculeSmall-Molecule Injectable Market Y-o-Y Growth (%) By Application, 2021–2031 Figure 16: Global Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Application, 2021–2031 Figure 17: Global Small MoleculeSmall-Molecule Injectable Market Share Analysis (%) By Route of Administration, 2021 & 2031 Figure 18: Global Small MoleculeSmall-Molecule Injectable Market Y-o-Y Growth (%) By Route of Administration, 2021–2031 Figure 19: Global Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Route of Administration, 2021–2031 Figure 20: Global Small MoleculeSmall-Molecule Injectable Market Share Analysis (%) By Distribution Channel, 2021 & 2031 Figure 21: Global Small MoleculeSmall-Molecule Injectable Market Y-o-Y Growth (%) By Distribution Channel, 2021–2031 Figure 22: Global Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Distribution Channel, 2021–2031 Figure 23: Global Small MoleculeSmall-Molecule Injectable Market Share Analysis (%) By Region, 2021 & 2031 Figure 24: Global Small MoleculeSmall-Molecule Injectable Market Y-o-Y Growth (%) By Region, 2021–2031 Figure 25: Global Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Region, 2021–2031 Figure 26: North America Small MoleculeSmall-Molecule Injectable Market Size Analysis, 2016–2020 Figure 27: North America Small MoleculeSmall-Molecule Injectable Market Forecast & Y-o-Y growth, 2021–2031 Figure 29: North America Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Product, 2021-2031 Figure 31: North America Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Route of Administration, 2021-2031 Figure 28: North America Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Country, 2021-2031 Figure 30: North America Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Application, 2021-2031 Figure 32: North America Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Distribution Channel, 2021-2031 Figure 33: Latin America Small MoleculeSmall-Molecule Injectable Market Size Analysis, 2016–2020 Figure 34: Latin America Small MoleculeSmall-Molecule Injectable Market Forecast & Y-o-Y growth, 2021–2031 Figure 35: Latin America Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Country, 2021-2031 Figure 36: Latin America Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Product, 2021-2031 Figure 37: Latin America Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Application, 2021-2031 Figure 38: Latin America Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Route of Administration, 2021-2031 Figure 39: Latin America Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Distribution Channel, 2021-2031 Figure 40: Europe Small MoleculeSmall-Molecule Injectable Market Size Analysis, 2016–2020 Figure 41: Europe Small MoleculeSmall-Molecule Injectable Market Forecast & Y-o-Y growth, 2021–2031 Figure 42: Europe Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Country, 2021-2031 Figure 43: Europe Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Product, 2021-2031 Figure 44: Europe Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Application, 2021-2031 Figure 45: Europe Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Route of Administration, 2021-2031 Figure 46: Europe Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Distribution Channel, 2021-2031 Figure 47: South Asia Small MoleculeSmall-Molecule Injectable Market Size Analysis, 2016–2020 Figure 48: South Asia Small MoleculeSmall-Molecule Injectable Market Forecast & Y-o-Y growth, 2021–2031 Figure 49: South Asia Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Country, 2021-2031 Figure 50: South Asia Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Product, 2021-2031 Figure 51: South Asia Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Application, 2021-2031 Figure 52: South Asia Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Route of Administration, 2021-2031 Figure 53: South Asia Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Distribution Channel, 2021-2031 Figure 54: East Asia Small MoleculeSmall-Molecule Injectable Market Size Analysis, 2016–2020 Figure 55: East Asia Small MoleculeSmall-Molecule Injectable Market Forecast & Y-o-Y growth, 2021–2031 Figure 56: East Asia Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Country, 2021-2031 Figure 57: East Asia Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Product, 2021-2031 Figure 58: East Asia Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Application, 2021-2031 Figure 59: East Asia Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Route of Administration, 2021-2031 Figure 60: East Asia Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Distribution Channel, 2021-2031 Figure 61: Oceania Small MoleculeSmall-Molecule Injectable Market Size Analysis, 2016–2020 Figure 62: Oceania Small MoleculeSmall-Molecule Injectable Market Forecast & Y-o-Y growth, 2021–2031 Figure 63: Oceania Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Country, 2021-2031 Figure 64: Oceania Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Product, 2021-2031 Figure 65: Oceania Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Application, 2021-2031 Figure 66: Oceania Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Route of Administration, 2021-2031 Figure 67: Oceania Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Distribution Channel, 2021-2031 Figure 68: MEA Small MoleculeSmall-Molecule Injectable Market Size Analysis, 2016–2020 Figure 69: MEA Small MoleculeSmall-Molecule Injectable Market Forecast & Y-o-Y growth, 2021–2031 Figure 70: MEA Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Country, 2021-2031 Figure 71: MEA Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Product, 2021-2031 Figure 72: MEA Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Application, 2021-2031 Figure 73: MEA Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Route of Administration, 2021-2031 Figure 74: MEA Small MoleculeSmall-Molecule Injectable Market Attractiveness Analysis By Distribution Channel, 2021-2031 Figure 75: U.S. Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031 Figure 76: U.S. Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031 Figure 77: U.S. Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031 Figure 78: U.S. Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031 Figure 79: U.S. Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031 Figure 80: Canada Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031 Figure 81: Canada Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031 Figure 82: Canada Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031 Figure 83: Canada Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031 Figure 84: Canada Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031 Figure 85: Brazil Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031 Figure 86: Brazil Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031 Figure 87: Brazil Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031 Figure 88: Brazil Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031 Figure 89: Brazil Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031 Figure 90: Mexico Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031 Figure 91: Mexico Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031 Figure 92: Mexico Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031 Figure 93: Mexico Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031 Figure 94: Mexico Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031 Figure 95: Argentina Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031 Figure 96: Argentina Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031 Figure 97: Argentina Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031 Figure 98: Argentina Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031 Figure 99: Argentina Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031 Figure 100: Germany Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031 Figure 101: Germany Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031 Figure 102: Germany Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031 Figure 103: Germany Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031 Figure 104: Germany Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031 Figure 105: Italy Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031 Figure 106: Italy Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031 Figure 107: Italy Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031 Figure 108: Italy Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031 Figure 109: Italy Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031 Figure 110: France Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031 Figure 111: France Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031 Figure 112: France Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031 Figure 113: France Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031 Figure 114: France Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031 Figure 115: U.K. Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031 Figure 116: U.K. Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031 Figure 117: U.K. Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031 Figure 118: U.K. Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031 Figure 119: U.K. Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031 Figure 120: Spain Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031 Figure 121: Spain Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031 Figure 122: Spain Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031 Figure 123: Spain Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031 Figure 124: Spain Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031 Figure 125: Benelux Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031 Figure 126: Benelux Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031 Figure 127: Benelux Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031 Figure 128: Benelux Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031 Figure 129: Benelux Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031 Figure 130: Russia Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031 Figure 131: Russia Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031 Figure 132: Russia Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031 Figure 133: Russia Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031 Figure 134: Russia Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031 Figure 135: China Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031 Figure 136: China Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031 Figure 137: China Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031 Figure 138: China Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031 Figure 139: China Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031 Figure 140: Japan Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031 Figure 141: Japan Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031 Figure 142: Japan Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031 Figure 143: Japan Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031 Figure 144: Japan Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031 Figure 145: South Korea Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031 Figure 146: South Korea Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031 Figure 147: South Korea Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031 Figure 148: South Korea Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031 Figure 149: South Korea Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031 Figure 150: India Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031 Figure 151: India Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031 Figure 152: India Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031 Figure 153: India Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031 Figure 154: India Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031 Figure 155: Thailand Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031 Figure 156: Thailand Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031 Figure 157: Thailand Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031 Figure 158: Thailand Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031 Figure 159: Thailand Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031 Figure 160: Malaysia Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031 Figure 161: Malaysia Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031 Figure 162: Malaysia Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031 Figure 163: Malaysia Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031 Figure 164: Malaysia Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031 Figure 165: Australia Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031 Figure 166: Australia Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031 Figure 167: Australia Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031 Figure 168: Australia Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031 Figure 169: Australia Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031 Figure 170: New Zealand Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031 Figure 171: New Zealand Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031 Figure 172: New Zealand Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031 Figure 173: New Zealand Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031 Figure 174: New Zealand Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031 Figure 175: GCC Countries Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031 Figure 176: GCC Countries Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031 Figure 177: GCC Countries Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031 Figure 178: GCC Countries Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031 Figure 179: GCC Countries Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031 Figure 180: South Africa Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Product, 2021 & 2031 Figure 181: South Africa Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Application, 2021 & 2031 Figure 182: South Africa Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Route of Administration, 2021 & 2031 Figure 183: South Africa Small MoleculeSmall-Molecule Injectable Market Share Analysis (%), by Distribution Channel, 2021 & 2031 Figure 184: South Africa Small MoleculeSmall-Molecule Injectable Market Value Analysis (US$ Bn), 2021 & 2031
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports